Similar Articles
1421 Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: Propensity score analysis
1422 Comparison of hepatic resection and transarterial chemoembolization for solitary hepatocellular carcinoma
1423 Radioembolization with Yttrium-90 microspheres in hepatocellular carcinoma: Role and perspectives
1424 Hepatitis D and hepatocellular carcinoma
1425 Chemotherapy and target therapy for hepatocellular carcinoma: New advances and challenges
1426 Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: An open question
1427 Preparation of magnetic resonance probes using one-pot method for detection of hepatocellular carcinoma
1428 Polymorphisms of glutathione S-transferase genes and survival of resected hepatocellular carcinoma patients
1429 Clostridium perfringens infection after transarterial chemoembolization for large hepatocellular carcinoma
1430 Six month abstinence rule for liver transplantation in severe alcoholic liver disease patients
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA